Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best mid cap stocks to buy according to hedge funds. On November 1, TD Cowen analyst Brendan Smith touted the progress the company has made ...
Block's sales and earnings missed Wall Street's targets in the third quarter. Revenue performance came in far weaker than expected. Block raised its full-year gross profit target, but higher costs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback